Sign in

CIK 0001101026

  • Non-accelerated filer
  • Smaller reporting company

Zivo Bioscience, Inc.

Sign in to watch
Ticker
ZIVO
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
870699977
Phone
+1 248-452-9866
Business address
21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS, MI, 48304
Former names
HEALTH ENHANCEMENT PRODUCTS INC, WESTERN GLORY HOLE INC
  1. 4 Open-market buy Director bought 668,522 shares at an average $0.12 ($82,258)
  2. 4 Open-market buy Director bought 14,441,202 shares at an average $0.11 ($1,523,804)
  3. 4 Open-market buy Director bought 340,029 shares at $0.09 ($30,603)
  4. 4 Open-market buy Director bought 45,000 shares at $0.08 ($3,600)
  5. 4 Open-market buy Director bought 70,000 shares at an average $0.07 ($4,950)
  6. 4 Open-market buy Director bought 15,000 shares at an average $0.08 ($1,250)
  7. 4 Open-market buy Director bought 82,500 shares at $0.09 ($7,425)
  8. 4 Open-market buy Director bought 40,000 shares at $0.09 ($3,600)
  9. 4 Open-market buy Director bought 30,100 shares at $0.09 ($2,709)
  10. 4 Open-market buy Director bought 55,000 shares at $0.09 ($4,950)
  11. 4 Open-market buy Director bought 45,000 shares at an average $0.11 ($5,000)
  12. 4 Open-market buy Director bought 95,000 shares at an average $0.12 ($11,120)
  13. 4 Open-market buy Director bought 496,000 shares at an average $0.11 ($54,830)
  14. 4 Open-market buy Director bought 90,000 shares at an average $0.10 ($9,400)
  15. 4 Open-market buy Director bought 85,400 shares at $0.11 ($9,394)
  16. 4 Open-market buy Director bought 724,500 shares at an average $0.12 ($88,985)
  17. 4 Open-market buy Director bought 213,000 shares at an average $0.12 ($26,170)
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market buy Director bought 61,689 shares at $0.17 ($10,487)
  20. 4 Open-market buy Director bought 5,017,000 shares at an average $0.10 ($502,380)

Page 6 of 12 · 239 filings